ONCOGENEX PHARMACEUTICALS, INC.

Company

ACHIEVE LIFE SCIENCES, INC.

Filed

September 2, 2008

Accession Number

0000950144-08-006838

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →